Registered entities
Anthera Pharmaceuticals, Inc.
Reg. No. 20-1852016United States
Investor mix
9 investors on record; lead investors include VantagePoint Capital Partners, Sofinnova Investments.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 67% |
| Private equity | 1 | 11% |
| Bank & private debt | 1 | 11% |
| Other / undisclosed | 1 | 11% |